A vaccine for coccidioidomycosis, or valley fever, has been effective in mouse studies and might be approved for use in dogs next year, and the drug nikkomycin Z has cured valley fever in mouse studies. Valley fever, caused by two types of Coccidioides fungi present in desert soil, damages the central nervous system, affects at least 10,000 to 15,000 people in the US annually, killing about 160, and the number of cases has been growing.
Valley fever vaccine might be available for dogs in 2021
Sign up for FBR SmartBrief
Biomedical Research News
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.